Nadine Gervois

Nantes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Unveiling the immune microenvironment in sinonasal intestinal type adenocarcinoma: new arguments for immunotherapy.

Unveiling the immune microenvironment in sinonasal intestinal type adenocarcinoma: new arguments for immunotherapy.

Journal: Oncoimmunology

Published: September 03, 2026

A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.

A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.

Journal: Science (New York, N.Y.)

Published: June 08, 2023

Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy.

Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy.

Journal: Frontiers in immunology

Published: December 21, 2022

A novel and efficient approach to high-throughput production of HLA-E/peptide monomer for T-cell epitope screening.

A novel and efficient approach to high-throughput production of HLA-E/peptide monomer for T-cell epitope screening.

Journal: Scientific reports

Published: June 21, 2021

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.

Journal: bioRxiv : the preprint server for biology

Published: May 20, 2021

High-Density of FcγRIIIA+ (CD16+) Tumor-Associated Neutrophils in Metastases Improves the Therapeutic Response of Cetuximab in Metastatic Colorectal Cancer Patients, Independently of the HLA-E/CD94-NKG2A Axis.

High-Density of FcγRIIIA+ (CD16+) Tumor-Associated Neutrophils in Metastases Improves the Therapeutic Response of Cetuximab in Metastatic Colorectal Cancer Patients, Independently of the HLA-E/CD94-NKG2A Axis.

Journal: Frontiers in oncology

Published: March 23, 2021

The Caspase-1/IL-18 Axis of the Inflammasome in Tumor Cells: A Modulator of the Th1/Tc1 Response of Tumor-Infiltrating T Lymphocytes in Colorectal Cancer.

The Caspase-1/IL-18 Axis of the Inflammasome in Tumor Cells: A Modulator of the Th1/Tc1 Response of Tumor-Infiltrating T Lymphocytes in Colorectal Cancer.

Journal: Cancers

Published: November 30, 2020

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.

Journal: European journal of immunology

Published: November 17, 2020

Transcriptomic features of tumour-infiltrating CD4lowCD8high double positive αβ T cells in melanoma.

Transcriptomic features of tumour-infiltrating CD4lowCD8high double positive αβ T cells in melanoma.

Journal: Scientific reports

Published: December 18, 2019

Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma.

Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma.

Journal: Cellular immunology

Published: June 18, 2019

The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression.

The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: March 28, 2019

Physiopathological mechanisms of immune-related adverse events induced by anti-CTLA-4, anti-PD-1 and anti-PD-L1 antibodies in cancer treatment

Physiopathological mechanisms of immune-related adverse events induced by anti-CTLA-4, anti-PD-1 and anti-PD-L1 antibodies in cancer treatment

Journal: Bulletin du cancer

Published: March 15, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026